Quantcast

Latest kidney transplant Stories

2010-11-11 06:30:00

KALAMAZOO, Mich., Nov. 11, 2010 /PRNewswire/ -- NephRx Corporation today announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients. Separately, NephRx announced...

2010-10-29 18:51:24

Older patients are twice as likely to get a kidney transplant than a decade ago Elderly patients with kidney failure get kidney transplants more often than they did a decade ago, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The results suggest that the chances of receiving a kidney transplant are better than ever for an older patient who needs one. Kidney failure afflicts nearly half a million individuals in the...

2010-10-01 13:53:54

South Asian men and women have more than twice the risk of suffering a heart attack after a kidney transplant, according to a study led by St. Michael's nephrologist Dr. Ramesh Prasad. The study, published today in the Clinical Journal of the American Society of Nephrology, studied 864 patients who underwent a transplant between 1998 and 2007. Researchers analyzed and compared the group's risk for a heart attack, angioplasty and bypass surgery rates, and death from heart disease after a...

2010-09-15 08:00:00

DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to transplant recipients and living donors from around the country to help them pursue their educational goals and gain even more power to make a real difference in the lives of the people around them. Scholarship winners were chosen from among 283 entries by a panel of judges who evaluated the...

2010-09-08 18:12:00

SAN ANTONIO, Texas, Sept. 8 /PRNewswire-USNewswire/ -- The Texas Transplant Institute kidney transplant program at Methodist Specialty and Transplant Hospital (MSTH) in San Antonio, Texas, home of the nation's largest live donor kidney transplant program in 2009*, published in today's New England Journal of Medicine that they have increased access to live donor kidney transplantation by 34% with kidney paired donation (KPD). The paired donor program identifies living donors who wish to...

2010-09-03 18:12:36

Non-kidney organ transplanted patients more likely to be listed preemptively for a kidney transplant than individuals without prior transplants Individuals who received a non-kidney organ transplant in the past may be more likely to be listed for a kidney transplant prior to initiation of dialysis (pre-emptive listing) than other candidates, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results indicate that the...

2010-05-25 08:58:19

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant. The findings come from the Immune Tolerance Network...

2010-05-25 08:06:13

Three new reports describe biomarkers that identify either kidney transplant recipients likely to maintain excellent and stable allograft function in the absence of immunosuppressive drugs or those at risk of losing their transplants. Peter Heeger and Bernd Schröppel, at Mount Sinai School of Medicine, New York, describe in an accompanying commentary, the importance of these studies and how they might impact the management of patients in the clinic to provide a more personalized...

2010-05-03 10:42:27

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine. The two-year results from the three-year BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial) and BENEFIT-EXT ("extended criteria") studies were presented Sunday at the...

2010-04-30 11:50:32

Kidney transplant recipients are known to have a higher risk of cancer, compared to the general population, due to the need to take immunosuppressive drugs to prevent organ rejection. Results published today from a significant, long-term study suggest that no single medication appears to increase this cancer risk. Evaluating data from 1983 in a randomized trial, researchers were able review trends among 481 patients over 20 years - providing the strongest evidence to date on the issue. A...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related